Tarsus to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Tarsus Pharmaceuticals (NASDAQ: TARS) announced management will participate in upcoming investor conferences in early March 2026. Presentations are scheduled at the TD Cowen 46th Annual Health Care Conference on March 3, 2026 at 11:30 a.m. PT / 2:30 p.m. ET and at the Barclays 28th Annual Global Healthcare Conference on March 11, 2026 at 9:30 a.m. PT / 12:30 p.m. ET.

Live webcasts and event details are available on the company website. Replays will be posted within 48 hours and archived for a limited time.

IRVINE, Calif., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), today announced that management plans to participate in the following upcoming investor conferences:

• TD Cowen 46^th Annual Health Care Conference on Tuesday, March 3^rd, at 11:30 a.m. PT / 2:30 p.m. ET.
• Barclays 28^th Annual Global Healthcare Conference on Wednesday, March 11^th, at 9:30 a.m. PT / 12:30 p.m. ET.

Live webcasts and additional information can be accessed on the events section of the Tarsus website. Replays will be available on the Tarsus website within 48 hours and will be archived for a limited time.

About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care and infectious disease prevention. XDEMVY^® (lotilaner ophthalmic solution) 0.25% is FDA approved in the United States for the treatment of Demodex blepharitis. Tarsus is also developing TP-04 as an ophthalmic gel for the potential treatment of ocular rosacea and TP-05 as an oral tablet for the potential prevention of Lyme disease, all of which are in Phase 2.

Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
AKemp@tarsusrx.com

Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com

FAQ

When will TARS present at the TD Cowen 46th Annual Health Care Conference?

TARS will present on March 3, 2026 at 11:30 a.m. PT / 2:30 p.m. ET. According to the company, the session will be available via live webcast and event details are posted on the Tarsus investor events page.

What time is TARS scheduled to speak at the Barclays 28th Annual Global Healthcare Conference?

TARS is scheduled for March 11, 2026 at 9:30 a.m. PT / 12:30 p.m. ET. According to the company, investors can access a live webcast and find additional participation details on the Tarsus website.

Where can investors watch the TARS live webcasts for the March 2026 conferences?

Investors can watch live webcasts on the Tarsus website events section. According to the company, live streaming links and supporting materials will be posted on the investor events page ahead of each presentation.

Will TARS provide replays of the March 2026 conference presentations?

Yes. According to the company, replays will be posted on the Tarsus website within 48 hours and will be archived for a limited time. Investors should check the events archive for replay availability and timing.

How can shareholders find additional information about TARS participation in the March 2026 conferences?

Shareholders can find details on the Tarsus investor events web page, including schedules and webcast links. According to the company, event materials and replay information will be available there before and after each presentation.